Andy joined NZP in April 2005 as General Manager, responsible for overall management & administration of the company, global procurement of key raw materials and key client management. In September 2009, Andy oversaw the acquisition of UK subsidiary (Dextra). In March 2010, Andy was appointed to the role of CEO of the company’s three subsidiaries, and is a Director on the company’s Board. Prior to NZP, Andy gained experience managing a number of manufacturing companies across Asia-Pacific, leading business mergers & transitions. Andy holds a BSc, and MBA (Massey University) and is a Member of the NZ Institute of Directors. Andy joined NZP in April 2005 as General Manager, responsible for overall management & administration of the company, global procurement of key raw materials and key client management. In September 2009, Andy oversaw the acquisition of UK subsidiary (Dextra). In March 2010, Andy was appointed to the role of CEO of the company’s three subsidiaries, and is a Director on the company’s Board. Prior to NZP, Andy gained experience managing a number of manufacturing companies across Asia-Pacific, leading business mergers & transitions. Andy holds a BSc, and MBA (Massey University) and is a Member of the NZ Institute of Directors.

Business Administration in pharma